l-carnitine cardiovascular and heart disease L-Carnitine | Metabolism & Fat
Description
Vagotomy for treatment of severe obesity
Date created: 9 July 2018
[DOI] [PubMed] [Google Scholar] 46.Weissman J.R., Kelley R.I., Bauman M.L., Cohen B.H., Murray K.F., Mitchell R.L., Kern R.L., Natowicz M.R
by contrast, U0126, an inhibitor of MAPK kinases, suppressed PFOS-mediated IRE1 overexpression, suggesting that ER stress is a downstream target of the ERK pathway (Fig
